Decheng to raise $450M life sciences fund

Decheng Capital (Shanghai, China) proposed to raise up to $450 million for its Decheng Capital China Life Sciences USD Fund III, according to an April 30 SEC filing.

The firm typically invests in early stage life science companies focused on pharmaceuticals, medical devices, diagnostics, manufacturing or healthcare services...